Condensed Consolidated Statement of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)	Common Stock	Preferred Stock	Common Stock Issuable	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2023	$ 27,597	$ 2,750	$ 281,682	$ 42,525,837	$ (42,033,136)	$ 804,730
Balance (in Shares) at Dec. 31, 2023	275,964,958	2,750,000
Sales of common stock	$ 510			255,413		255,923
Sales of common stock (in Shares)	5,100,000
Fair value of warrants allocated to proceeds of common stock				99,077		99,077
Fair value of warrants allocated to proceeds of related party debt				209,943		209,943
Fair value of beneficial conversion feature allocated to proceeds of related party debt				146,405		146,405
Consultant and director fees payable with common shares and warrants			43,437			43,437
Shares and options issued to employees			(270,549)	320,246		49,697
Net loss					(1,387,718)	(1,387,718)
Balance at Mar. 31, 2024	$ 28,107	$ 2,750	54,570	43,556,921	(43,420,854)	221,494
Balance (in Shares) at Mar. 31, 2024	281,064,958	2,750,000
Balance at Dec. 31, 2024	$ 28,195	$ 2,750	161,632	44,842,829	(48,164,615)	(3,129,209)
Balance (in Shares) at Dec. 31, 2024	281,947,151	2,750,000
Sales of common stock			3,245			3,245
Fair value of warrants allocated to proceeds of common stock				6,755		6,755
Stock fees related to sales of common stock			3,000	(3,000)
Fair value of warrants to extend related party debt				25,625		25,625
Shares and options issued to employees				7,126		7,126
Net loss					(1,050,939)	(1,050,939)
Balance at Mar. 31, 2025	$ 28,195	$ 2,750	$ 167,877	$ 44,879,335	$ (49,215,554)	$ (4,137,397)
Balance (in Shares) at Mar. 31, 2025	281,947,151	2,750,000